AIDS
Viiv Healthcare’s cabotegravir effective in HIV prevention in women
November 9, 2020Sales and Marketing AIDS, HIV
Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …
Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease
June 19, 2020Medical Communications AIDS, HIV, mosquitoes
Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …
Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women
March 10, 2020Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin
Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …
Uganda finalising clinical trials on new injectable HIV drug
March 9, 2020Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda
Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …
Lack of mental health treatment available for HIV patients in the UK
March 6, 2020Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS
A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …
Rapid testing to help combat worst UK outbreak of HIV in 30 years
February 18, 2020Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS
New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …
Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds
February 5, 2020Research and Development AIDS, HIV, STDs, STIs, UK, sexual health
The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
HIV infections fall by 73% in bi and gay British men
January 16, 2020Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …
Labour and Lib Dems make election pledge for wider access to HIV drug
December 2, 2019Sales and Marketing AIDS, Conservatives, HIV. HIV Drugs, Labour Party, Liberal Democrats, lib dems
The Labour Party and the Liberal Democrats have both pledged to roll out access to pre-exposure prophylaxis (PrEP) therapy for …
Gilead challenges Government over patents on preventative HIV drug Truvada
August 22, 2019Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents
Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …
GSK’s two drug HIV regimen effective when administered every two months
August 22, 2019Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression
GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …
Scientists use duoCAR-T therapy to fight HIV
August 9, 2019Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma
Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …
Gilead’s PrEP drug Descovy should be approved for men and transgender women but not cis-gender women, FDA advisory panel says
August 8, 2019Research and Development AIDS, Gilead, HIV, PrEP, descovy, pharma
Independent experts on a panel advising the FDA have voted in favour of Gilead’s new PrEP drug Descovy in men …
MSD trials long lasting PrEP implant for preventing HIV
July 23, 2019Research and Development AIDS, HIV, MSD, PrEP, pharma
MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …
ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial
July 10, 2019Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma
Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …
